ArticleBMC bioinformatics2026
UniPTMs: a unified multi-type PTM site prediction model via master-slave architecture-based multi-stage fusion strategy and hierarchical contrastive loss.
Article in BMC bioinformatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- CLASPP: A unified model for predicting post-translational modifications.PLoS computational biology · 2026Article
- CLASPP: A unified model for predicting post-translational modifications.bioRxiv : the preprint server for biology · 2026Article
- An SE(3)-equivariant and dynamic multi-modal engine advancing from PTM site prediction to network understanding.Communications chemistry · 2026Article
- UniGraphPTMs: a contrastive learning-enhanced universal framework for PTM site prediction via GNN and multimodal fusion.BMC genomics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundAs a core mechanism of epigenetic regulation in eukaryotes, protein post-translational modifications (PTMs) require precise prediction to decipher dynamic life activity networks. To address the limitations of existing deep learning models in cross-modal feature fusion, domain generalization, and architectural optimization, this study proposes UniPTMs: a unified framework for multi-type PTM prediction.
resultsThe framework innovatively establishes a "Master-Slave" dual-path collaborative architecture: the master path dynamically integrates high-dimensional representations of protein sequences, structures, and evolutionary information through a bidirectional gated cross-attention module, while the slave path optimizes feature discrepancies and recalibration between structural and traditional features using a low-dimensional fusion network. Complemented by a multi-scale adaptive convolutional pyramid for capturing local feature patterns and a bidirectional hierarchical gated fusion network enabling multi-level feature integration across paths, the framework employs a hierarchical dynamic weighting fusion mechanism to intelligently aggregate multimodal features. Enhanced by a novel hierarchical contrastive loss function for feature consistency optimization, UniPTMs demonstrates significant performance improvements (3.2-11.4% Matthews correlation coefficient and 4.2-14.3% average precision increases) over state-of-the-art models across five modification types. Additionally, to strike a balance between model complexity and performance, we have developed a lightweight variant named UniPTMs-mini.
conclusionsUniPTMs successfully transcends the single-type prediction paradigm, providing a unified and highly accurate approach for multi-type PTM prediction. This robust architecture, alongside its lightweight variant, offers a powerful and practical tool for advancing epigenetic research and further deciphering dynamic life activity networks.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.